国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

400-885-9898
更新于 8月25日
智聯(lián)APPAPP
舉報(bào)

間接采購經(jīng)理（臨床研發(fā)）(J17662)

2-3萬·16薪
  • 上海徐匯區(qū)
  • 5-10年
  • 本科
  • 全職
  • 招1人

職位描述

英語間采臨床
崗位職責(zé):
1. Category management –R&D categories（臨床研發(fā)服務(wù)品類）
a) Assure clear understanding of business needs and imperatives in conjunction to business strategy/roadmap through excellent business engagement scheme.
b) Master of the market movements and intelligence for accountable category with presented insights and proficiency.
c) Define and develop category strategy in linking supply market and business needs to sustain the business growth.
d) Action plan development and deployment based on defined category strategy.
e) Measure and track the performance and outputs of the deployed category strategy at rolling base with needful optimization and rectification for set deliverables.
f) Manage the category strategy escalation in terms of market dynamics and business movement.
g) achieve cost saving goals
2. Supplier sourcing and relationship management
a) Set up PSL for managed categories in line with procurement policy and guidance.
b) Manage the SRM cycle as per SRM framework to track/evaluate supplier performance with set KPIs to continuously drive performance improvement and superior customer experience.
c) Proactively work with suppliers to explore/excavate/deploy innovative solutions for added value to business on top of fulfillment of SRM framework.
d) Manage the supplying risks including but not limited to supply continuity, compliance, quality assurance, legitimate exposure, IP etc.
3. Business engagement
a) As Business Partner (BP), engage and collaborate with business in deep understanding business needs, including business imperatives, priorities and projects for optimal solutions by leveraging business operation continuity, spend management, risk management and value creation.
b) Communicate and align with business for category/sourcing strategy as well as action plan deployment
4. Project management
a) Engage/Lead the projects that has significant impacts on business in term of broadness and depth.
b) Manage the complexities and ambiguity with demonstrated business acumen and agility
c) Commitment to results
5. Compliance and risk management
a) Be fully compliant to corporate/company RCM/audit/compliance regulations across entire cycle of category management, SRM, sourcing event management.
b) Conduct supplier DD following SRM management portfolio, work with Legal and Compliance office for risk assessment and risk mitigation plan/execution if needed.
c) Engage in corporate/company internal/3rd party audit, CAPA deployment and other remediation actions to fulfill the compliance commitment
d) Other risk management, including BCP, quality assurance, IP, adherence to statutory regulation etc.
任職要求:
? Bachelor degree minimum
? 7 years + sourcing and operation experience, MNC background would be a plus.
? R&D procurement management is a MUST, especially experience related to biopharmaceutical research and development in Clinical Depot, IRT, EDC, Ancillary, RA, Pharmacovigilance, Discovery and Preclinical. Sourcing experience in multi - regional clinical trials would be an added advantage.
? Strategic thinking with proficient knowledge around strategic sourcing, category management, SRM and purchasing operation excellence.
? Procurement system knowledge (Oracle, SAP, Ariba etc.)
? Willing to work under pressure and show-case expertise in managing ambiguity and uncertainties by demonstrated business acumen and agilities
? Good communication skills, self-motivated and be customer/result-driven.
? Good command of English, both oral and written.

工作地點(diǎn)

徐匯區(qū)上海復(fù)宏漢霖生物技術(shù)股份有限公司

職位發(fā)布者

鄒女士/HR

昨日活躍
立即溝通
公司Logo上海復(fù)宏漢霖生物技術(shù)股份有限公司
復(fù)宏漢霖（2696.HK）是一家國(guó)際化的創(chuàng)新生物制藥公司，致力于為全球患者提供可負(fù)擔(dān)的高品質(zhì)生物藥，產(chǎn)品覆蓋腫瘤、自身免疫疾病、眼科疾病等領(lǐng)域，已在中國(guó)上市5款產(chǎn)品，在國(guó)際上市1款產(chǎn)品，18項(xiàng)適應(yīng)癥獲批，3個(gè)上市申請(qǐng)分別獲中國(guó)藥監(jiān)局、美國(guó)FDA和歐盟EMA受理。自2010年成立以來，復(fù)宏漢霖已建成一體化生物制藥平臺(tái)，高效及創(chuàng)新的自主核心能力貫穿研發(fā)、生產(chǎn)及商業(yè)運(yùn)營(yíng)全產(chǎn)業(yè)鏈。公司已建立完善高效的全球創(chuàng)新中心，按照國(guó)際藥品生產(chǎn)質(zhì)量管理規(guī)范（GMP）標(biāo)準(zhǔn)進(jìn)行生產(chǎn)和質(zhì)量管控，不斷夯實(shí)一體化綜合生產(chǎn)平臺(tái)，其中，上海徐匯基地已獲得中國(guó)和歐盟GMP認(rèn)證，松江基地（一）也已獲得中國(guó)GMP認(rèn)證。復(fù)宏漢霖前瞻性布局了一個(gè)多元化、高質(zhì)量的產(chǎn)品管線，涵蓋20多種創(chuàng)新單克隆抗體，并全面推進(jìn)基于自有抗PD-1單抗H藥漢斯?fàn)?的腫瘤免疫聯(lián)合療法。繼國(guó)內(nèi)首個(gè)生物類似藥漢利康?（利妥昔單抗）、中國(guó)首個(gè)自主研發(fā)的中歐雙批單抗藥物漢曲優(yōu)?（曲妥珠單抗，歐洲商品名：Zercepac?，澳大利亞商品名：Tuzucip?和Trastucip?）、漢達(dá)遠(yuǎn)?（阿達(dá)木單抗）和漢貝泰?（貝伐珠單抗）相繼獲批上市，創(chuàng)新產(chǎn)品漢斯?fàn)?（斯魯利單抗）已獲批用于治療微衛(wèi)星高度不穩(wěn)定（MSI-H）實(shí)體瘤、鱗狀非小細(xì)胞肺癌和廣泛期小細(xì)胞肺癌，成為全球首個(gè)獲批一線治療小細(xì)胞肺癌的抗PD-1單抗，其食管鱗狀細(xì)胞癌適應(yīng)癥的上市注冊(cè)申請(qǐng)也正在審評(píng)中。公司亦同步就16個(gè)產(chǎn)品在全球范圍內(nèi)開展30多項(xiàng)臨床試驗(yàn)。
公司主頁